These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 2889354)
21. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders]. De Natale G; De Natale F; Marino A Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647 [TBL] [Abstract][Full Text] [Related]
22. Ranitidine v. cimetidine in peptic ulcer. Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213 [No Abstract] [Full Text] [Related]
23. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease]. Simon B; Müller P; Dammann HG Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962 [TBL] [Abstract][Full Text] [Related]
24. Overview of the safety profile of the H2-receptor antagonists. Hansten PD DICP; 1990 Nov; 24(11 Suppl):S38-41. PubMed ID: 1980183 [TBL] [Abstract][Full Text] [Related]
25. [The status of H2-blocker therapy today]. Rameis H Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029 [TBL] [Abstract][Full Text] [Related]
26. Drug therapy of peptic ulcer disease. Peppercorn MA Compr Ther; 1983 Nov; 9(11):47-52. PubMed ID: 6139199 [TBL] [Abstract][Full Text] [Related]
27. [The H2-antagonist therapy withdrawal syndrome: the possible role of hyperprolactinemia]. Rampello L; Nicoletti G Medicina (Firenze); 1990; 10(3):294-6. PubMed ID: 1981922 [TBL] [Abstract][Full Text] [Related]
28. Safety issues relating to long-term treatment with histamine H2-receptor antagonists. Sabesin SM Aliment Pharmacol Ther; 1993; 7 Suppl 2():35-40. PubMed ID: 8103374 [TBL] [Abstract][Full Text] [Related]
29. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects]. Carrasco M; Gaule C; Vega P; del Villar E Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175 [TBL] [Abstract][Full Text] [Related]
30. Clinical importance of the new H2-antagonists. Walt RP Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730 [TBL] [Abstract][Full Text] [Related]
31. [Possibly ranitidine-induced autoimmune hepatitis]. Luparini RL; Rotundo A; Mattace R; Marigliano V Ann Ital Med Int; 2000; 15(3):214-7. PubMed ID: 11059062 [TBL] [Abstract][Full Text] [Related]
32. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists. Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855 [TBL] [Abstract][Full Text] [Related]
33. A comparative evaluation of cimetidine and ranitidine. Zimmerman TW; Schenker S Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770 [No Abstract] [Full Text] [Related]
34. [What is important in treating elderly with H2 receptor antagonists]. Kurosawa S Nihon Rinsho; 2002 Aug; 60(8):1613-7. PubMed ID: 12187760 [TBL] [Abstract][Full Text] [Related]
35. [Recent aspects of drug interactions with the H2 antagonists cimetidine and ranitidine. A review of the literature]. Kirch W; Ohnhaus EE Med Klin (Munich); 1987 May; 82(11):400-4. PubMed ID: 3600542 [No Abstract] [Full Text] [Related]